LSE:AZN (AstraZeneca PLC)
About AZN
AstraZeneca is a biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas - Respiratory, Inflammation and Autoimmunity (RIA), Cardiovascular and Metabolic Disease (CVMD) and Oncology – as well as in Infection and Neuroscience.
AstraZeneca PLC (LSE: AZN) Latest News
Investing Articles
Best British shares to buy in November
Investing Articles
What on earth is going on with the AstraZeneca share price?
Investing Articles
6 super investors hold this FTSE 100 stock. Should I buy it too?
Investing Articles
Down 10%, the most valuable stock on the FTSE 100 is starting to look cheap!
Investing Articles
2 FTSE 100 shares to buy in the UK stock market crash
Investing Articles
2 no-brainer value stocks I think I’ll buy for Q4
Investing Articles
If I’d invested £1,000 in AstraZeneca shares at the start of 2022, here’s what I’d have now
Investing Articles
1 FTSE 100 stock that should continue to outperform long term
Page
Investing in Blue-Chip Companies: Top UK Blue-Chip Stocks in 2022
Investing Articles
Is this FTSE 100 pharma giant a growth stock in disguise?
Page
Investing in Healthcare: Top UK Healthcare Stocks in 2022